Does Blue Cross Blue Shield cover Zepbound, Wegovy and other GLP-1s for weight loss in 2026?
Each Blue company, and often each employer, writes its own drug rules, so the real answer sits in your plan documents. Zepbound from Lilly and Wegovy from Novo Nordisk are the two best-known brand-name GLP-1 weight-loss drugs, and you can check your plan for both in minutes.
Medically reviewed by Jill Garnier, MDSometimes: Blue Cross Blue Shield is more than 30 separate companies, and several now exclude weight-loss drugs unless your employer adds them. With coverage, Lilly's savings card can bring Zepbound to about $25 a month, and eligible Blue Medicare members pay $50. If your plan says no, Lilly's self-pay KwikPen costs about $300 to $450 a month, by dose.
On this page
- What you'll actually pay
- Every way to pay for Zepbound or Wegovy with a Blue Cross plan, option by option
- Does Blue Cross Blue Shield cover Zepbound?
- Why two Blue Cross cards can give two different answers
- Does BCBS cover GLP-1s for weight loss in 2026? What the Blue plans publish
- Does Blue Cross cover Wegovy?
- How to check your own BCBS plan in 5 minutes
- What you'll pay when your Blue plan covers it
- BCBS prior authorization for Zepbound and Wegovy: what Blue plans ask
- Your Blue plan excludes weight-loss drugs: routes that still work
- Not covered by BCBS: the cheapest ways to get a GLP-1
- Blue Cross Medicare plans: the $50 GLP-1 Bridge
- What a year costs on a Blue plan, covered vs not
- Frequently asked questions
What you'll actually pay
We may earn a commission if you sign up through a link. It never affects the ranking. How we review
- Single-dose pen
- Card pays up to $100 a month, $1,300 a year
- Commercial plans only
- Pen or pill, any dose
- Card pays up to $100 a month
- Not for Medicare or Medicaid
- Wegovy, Foundayo or Zepbound KwikPen
- Jul 1, 2026 to Dec 31, 2027
- BMI rules apply
- Price rises with the dose
- Top price needs a refill within 45 days
- Otherwise about $500–$700
- Same price insured or not
- Pen about $200 for the first 2 fills at starting doses, through Dec 31, 2026
- Same price insured or not
Show 3 more options
- About $40 first month
- Low price of about $75/mo needs a 12-month prepay
- Files your PA
- Not for Medicaid
- First month free, not in every state
- Low price of about $50/mo needs a 12-month prepay
- Helps with PA
- HSA and FSA accepted
- Not Wegovy
- Not FDA-approved
- Never billed to a Blue plan
- Same price at every dose
Start with the kind of Blue coverage you have. It decides almost everything below.
- Your Blue plan covers Zepbound or Wegovy: get the plan's advance approval, called prior authorization, then add the maker's savings card.
- Your plan excludes weight-loss drugs: ask whether a sleep apnea or heart diagnosis opens another door. Then ask HR whether weight-loss coverage can be added.
- You have a Blue Medicare plan: the GLP-1 Bridge is the main door, at $50 a month if you meet its rules.
- The answer is still no: the makers' self-pay prices are the same whether you have insurance or not.
Every way to pay for Zepbound or Wegovy with a Blue Cross plan, option by option
Blue plan covers Zepbound, plus Lilly's savings card: Zepbound with coverage
This is Lilly's copay coupon for commercial plans, meaning coverage through an employer or the marketplace. Your Blue plan must already cover Zepbound.
You can pay as little as $25 for a fill of the single-dose pen. The card pays up to $100 a month and up to $1,300 a year.
The pen type matters on Blue plans. Blue Cross and Blue Shield of Oklahoma keeps the single-dose pen for self-funded employers that buy weight-loss coverage. It leaves off the KwikPen, a multi-dose pen, because Lilly sells it only through self-pay channels.
Blue plan covers Wegovy, plus Novo's savings card: Wegovy with coverage
Novo Nordisk's card works the same way for commercial plans. You pay as little as $25, and the card pays up to $100 a month, for the pen or the pill.
Novo's terms shut the card off on plans that run copay accumulator or maximizer programs. Both are plan rules that change how coupon money counts toward your deductible.
The card still helps when your Blue plan says no. In that case, the pharmacist runs it to give you Novo's self-pay price at a regular pharmacy.
Blue Medicare plan plus the GLP-1 Bridge: best on Medicare
Since July 1, 2026, eligible members of Blue Medicare drug plans can get Wegovy, Foundayo or the Zepbound KwikPen for $50 a month. Who qualifies is explained in the Medicare section below.
Lilly self-pay KwikPen or vial: Zepbound if your plan says no
Lilly sells the KwikPen and vials at the same self-pay prices for everyone, whether you have insurance or not. Since March 16, 2026, the KwikPen has been sold at that price in major retail pharmacies, not only through LillyDirect, Lilly's online pharmacy.
- 2.5 mg: about $300 for four weeks.
- 5 mg: about $400.
- 7.5 mg to 15 mg: about $450, if you refill within 45 days of your last delivery.
- Late refill: about $500 at 7.5 mg and about $700 from 10 mg up.
NovoCare self-pay Wegovy: Wegovy if your plan says no
NovoCare is Novo Nordisk's direct program. Its prices are the same for insured and uninsured women, and the pill is the cheaper format.
- Pill: about $150 at the first dose, about $200 at the second, then about $300 a month.
- Pen, first two fills: about $200 each at the two starting doses, for new patients through December 31, 2026.
- Pen after that: about $350 a month, or about $400 for the highest dose, Wegovy HD.
Ro: best for full-service insurance help
Ro's insurance team gathers your records, files the prior authorization and talks to your plan. Prior authorization is the plan's approval before it pays, and Ro says the review usually takes one to two weeks.
Ro can bill insurance for the Wegovy pen, the single-dose Zepbound pen and Ozempic. It also offers this help to members of federal employee plans, which include FEP Blue.
The Ro Body membership is about $150 a month after a first month of about $40. Prepaying a year brings it to about $75 a month, and insurance never pays the membership.
Ro does not treat Medicaid members and offers Medicare members cash options only. Its weight program is not offered in Hawaii, Louisiana, Mississippi or Virginia. Ro holds 3.9 stars on Trustpilot from about 6,800 reviews, and our Ro insurance review has the details.
Mochi Health: lowest membership with PA help
Mochi's medical assistant team contacts your insurer, files prior authorizations and writes letters of medical necessity. Once approved, you pay your plan's copay for the drug.
The membership is about $80 a month, with the first month free for new members, though not in every state. A prepaid year brings it to about $50 a month, and HSA or FSA money is accepted.
Mochi also sells a Covered With Mochi plan for private insurance, at about $120 for six months or about $200 for a year. Visits are billed to your plan, and the medicine is billed separately. Mochi holds 4.5 stars on Trustpilot from about 18,800 reviews. Our Mochi Health insurance review has the rest.
JoinSkinny compounded semaglutide: a cash option outside your plan
JoinSkinny charges about $150 every 28 days for compounded semaglutide, and the price stays the same as the dose rises. It is not Wegovy, it is not FDA-approved, and no Blue plan pays for it. Our compounded GLP-1 guide explains where it stands.
Does Blue Cross Blue Shield cover Zepbound?
It can, but only if your plan includes the reason on your prescription. The FDA has approved Zepbound for two uses.
- Weight: for adults with a BMI of 30 or more, or 27 or more with a weight-related condition, alongside diet and activity.
- Sleep apnea: for moderate to severe obstructive sleep apnea in adults with obesity. In this condition, the airway keeps closing during sleep.
A Blue plan that covers weight-loss drugs usually covers Zepbound after a prior authorization. A plan that excludes them blocks the weight use, and the sleep apnea use depends on the company.
BCBS of South Carolina shows how strict this can get. On plans without weight-loss coverage, it does not review Zepbound for sleep apnea at all. Our Zepbound insurance guide covers the drug in more depth.
Why two Blue Cross cards can give two different answers
Blue Cross Blue Shield is not one insurer. It is a group of more than 30 independent companies that share a name and a national network.
Each company sets its own drug rules. Then your employer's plan type decides who has the final word.
- Fully insured plan: your employer buys a ready-made plan from the Blue company. The Blue company's own drug policy applies.
- Self-funded plan: your employer pays claims itself and uses the Blue company to run the plan. Your employer decides whether weight-loss drugs are covered.
- The PBM: a pharmacy benefit manager, or PBM, runs the drug list. Anthem plans use CarelonRx, many Blues use Prime Therapeutics, and others use CVS Caremark or another PBM.
Your card holds the clues. The three letters before your member ID, called the prefix, tell pharmacies which Blue company holds your plan. The pharmacy phone line on the back usually reaches the PBM.
Does BCBS cover GLP-1s for weight loss in 2026? What the Blue plans publish
Does Anthem cover Zepbound?
Anthem is the Blue brand of Elevance Health, offered in 14 states. Its drug lists run through CarelonRx, Elevance's own PBM.
Whether Zepbound is covered depends on your employer's plan and the drug list it uses. Search for Zepbound by name in the Sydney Health app or on Anthem's member site, then look for a PA code.
Blue companies with a published weight-loss drug policy
These Blue companies have put their rules in writing. Each notice covers certain plan types, so match it to yours.
- BCBS of Michigan: for fully insured large-group plans, weight-loss coverage of Wegovy and Zepbound ended on January 1, 2025, or at the 2025 renewal. Self-funded employers can still choose to cover them.
- BCBS of Massachusetts: Wegovy and Zepbound for obesity are excluded starting January 1, 2026, and at each renewal through 2026. The exclusion also covers other uses, such as heart disease prevention.
- More on Massachusetts: coverage continues only if your employer buys an add-on, called a rider. The company says it makes no exceptions and the exclusion cannot be appealed.
- Blue Cross VT: weight-loss GLP-1s became a benefit exclusion on January 1, 2026. Wegovy stays covered for adults with heart disease and obesity, to lower heart risk.
- Florida Blue: weight-loss drugs are excluded from its plans. Weight-loss coverage applies only to self-insured employers that bought it.
- Independence Blue Cross: since January 1, 2025, its fully insured group and individual plans do not cover drugs prescribed only for weight loss. GLP-1s for diabetes and heart disease stay covered with prior authorization.
- BCBS of Oklahoma: for self-funded groups, weight-loss GLP-1 coverage is an option the employer chooses. Groups that choose it get the single-dose Zepbound pen and Wegovy, including Wegovy HD.
- BCBS of South Carolina: since August 1, 2026, plans without weight-loss coverage may cover Wegovy to lower heart risk or treat MASH, a liver disease. Each use needs a prior authorization.
Diabetes drugs are a separate story. BCBS of Massachusetts and Independence Blue Cross say GLP-1s for type 2 diabetes, such as Ozempic and Mounjaro, stay covered.
Federal Employee Program: FEP Blue
FEP Blue says it covers weight-loss drugs to treat obesity for Service Benefit Plan members who meet its criteria and get prior approval. Standard, Basic and Focus each have their own drug list, so search yours by name.
The rules tighten in 2027. OPM, the federal benefits office, told every federal plan to cover at least one GLP-1 for weight loss, but only alongside an intensive lifestyle program. You must take part in it before you start and while you take the drug.
Does Blue Cross cover Wegovy?
The same plan logic applies, with one big difference. Wegovy has two approved uses beyond weight, and some Blue plans pay for those even when weight loss is excluded.
- Heart risk: since March 2024, Wegovy is approved to lower the risk of heart attack and stroke in adults with heart disease and excess weight.
- Liver disease: since August 2025, it is approved for MASH with moderate to advanced scarring of the liver.
Blue Cross VT, Independence Blue Cross and BCBS of South Carolina keep a door open for the heart use. BCBS of Massachusetts does not.
The Wegovy pill, approved in December 2025, can sit on a drug list as its own entry. Look up the pill and the pen separately. Our Wegovy insurance guide has the drug-level details.
Foundayo is Lilly's daily GLP-1 pill, approved in April 2026. BCBS of Oklahoma accepts coverage exception requests for it, and our Foundayo cost page has its prices.
How to check your own BCBS plan in 5 minutes
You do not need to wait for a denial letter. Have your Blue card and your member login ready.
- Log in to your Blue company's member site or app: the drug search usually sits under pharmacy or prescriptions.
- Search the formulary: the formulary is the plan's list of covered drugs. Search Zepbound, Wegovy and the Wegovy pill one by one.
- Read the codes: PA means prior authorization is needed. QL is a quantity limit, and ST, step therapy, means you must try another drug first.
- Check the pen type: see whether the list shows the single-dose Zepbound pen, the KwikPen or vials. The $25 card names the single-dose pen.
- Check the tier: the tier tells you whether you pay a copay, a flat amount, or coinsurance, a share of the drug's price.
Questions for HR or the pharmacy line on your card
- Is our plan self-funded? If yes, your employer, not the Blue company, decides on weight-loss drugs.
- Is there a weight-loss drug exclusion? Ask whether it also blocks Zepbound for sleep apnea and Wegovy for heart risk.
- Can a rider be added? Some employers buy weight-loss coverage as an add-on to the plan.
- How are coupons counted? Ask whether the plan uses a copay accumulator or maximizer program.
- Does anything change on January 1, 2027? Fall is open enrollment season, and many plans announce next year's changes now.
Read your 2027 plan documents as soon as they arrive. If you have a spouse with work coverage, check that plan's weight-loss rules too.
What you'll pay when your Blue plan covers it
Covered does not mean one fixed price. Three parts of your plan decide what you pay at the counter.
- Copay: a flat amount for each fill. This is the easiest case for the savings cards.
- Coinsurance: a percentage of the plan's price for the drug. Even a small share adds up fast on a drug that lists above $1,000 a month.
- Deductible: what you pay yourself each year before the plan starts sharing costs. Until you meet it, you may owe the plan's full price.
The list price is the maker's official price before discounts. Coinsurance and deductibles are figured from it, not from the self-pay prices.
Wegovy's list price drops to about $675 a month on January 1, 2027. If you pay coinsurance or have a high deductible, your share of Wegovy should fall with it.
The savings card fine print
- Zepbound card: the single-dose pen only, up to $100 a month and $1,300 a year, for up to 13 fills. The current card expires on December 31, 2026.
- Wegovy card: the pen or the pill, up to $100 a month for a one-month fill.
- Who is left out: anyone on Medicare, Medicaid or another government plan, even with a work plan on top.
- The January trap: a high deductible resets each January, so the first fills of the year can cost far more than $25.
Activation steps are on our Zepbound savings page and our Wegovy savings card page.
BCBS prior authorization for Zepbound and Wegovy: what Blue plans ask
Blue plans that cover these drugs ask for much the same proof. Your prescriber sends it, and having it ready speeds things up.
- Your BMI, with a date: most plans follow the label, a BMI of 30 or more, or 27 or more with a weight-related condition.
- Diagnosed conditions: high blood pressure, prediabetes, high cholesterol, sleep apnea or heart disease, each written in your chart.
- Sleep apnea route: a sleep study showing moderate to severe sleep apnea, for Zepbound.
- Heart route: records of a past heart attack, stroke or blocked arteries, for Wegovy.
- Lifestyle records: notes from a diet, exercise or behavior program. Some plans set a minimum length.
- Renewal: approvals last a set time, and renewal usually asks for proof the drug is working.
Dose steps, which plans check at renewal, are in our Zepbound dosage guide and Wegovy dosage guide.
For women over 40: what counts and what does not
Menopause weight gain on its own does not qualify. Menopause is not an approved use for either drug, and Blue plans do not list it as a criterion.
What counts is your BMI and the conditions in your chart. Blood pressure, blood sugar and cholesterol often shift in the 40s and 50s, so make sure each diagnosis is written down before the request goes out.
Sleep apnea deserves a look too. In a large Wisconsin study, women after menopause were more likely to have sleep apnea than women before it, even after accounting for age and body size.
Our guide to perimenopause weight-loss medication explains how these drugs fit this stage of life.
Your Blue plan excludes weight-loss drugs: routes that still work
An exclusion is not always the end. Which routes stay open depends on your Blue company.
- Sleep apnea route: a sleep study showing moderate to severe sleep apnea can support a Zepbound request on plans that review it.
- Heart or liver route: Wegovy for heart risk or MASH is reviewed on its own at several Blue companies.
- Formulary exception: your prescriber asks the plan to cover a drug it does not list. It works best with a clear medical reason.
- Employer rider: ask HR whether weight-loss coverage can be added at the next renewal.
- Open enrollment: compare plans on these drugs, not just on premiums, including a spouse's plan.
If the denial was about missing paperwork, appeal it. You have 180 days to file an internal appeal, and the plan must decide within 30 days for a drug you have not started.
If the plan says no again, you can ask for an independent external review. A plan exclusion, like the one at BCBS of Massachusetts, usually cannot be appealed. The full appeal steps are in our Zepbound insurance guide.
Not covered by BCBS: the cheapest ways to get a GLP-1
A no from your Blue plan does not send you to the list price. The makers sell directly at the same price for everyone.
- Wegovy pill from NovoCare: about $150 a month at the first dose, then about $300 at the usual doses.
- Zepbound KwikPen or vials from Lilly: about $300 to $450 a month, at LillyDirect or major pharmacies.
- Wegovy pen from NovoCare: about $350 a month after two starter fills at about $200.
- Zepbound card offer for excluded plans: the single-dose pen from about $500 a month. That costs more than the self-pay KwikPen at every dose.
- TrumpRx.gov: a government site that lists the makers' self-pay prices. It never uses your insurance.
Compounded semaglutide and tirzepatide cost less, but they are not FDA-approved and no Blue plan pays for them. Our compounded GLP-1 guide explains the trade-offs.
Our GLP-1 without insurance page ranks every cash route. For Zepbound alone, see the cheapest ways to get Zepbound.
Blue Cross Medicare plans: the $50 GLP-1 Bridge
Medicare's drug coverage, called Part D, still cannot pay for drugs used only for weight loss. The GLP-1 Bridge is a separate federal program that runs alongside your Blue Medicare plan.
- What it covers: Wegovy pen or pill, Foundayo and the Zepbound KwikPen. Single-dose Zepbound pens and vials are left out.
- Price: $50 for a one-month supply. It does not count toward your Part D deductible or yearly limit, and Extra Help does not lower it.
- BMI of 35 or more: you qualify with no other condition.
- BMI of 30 or more: you also need heart failure with preserved ejection fraction, uncontrolled high blood pressure, or kidney disease at stage 3a or worse.
- BMI of 27 or more: you also need prediabetes, a past heart attack or stroke, or blocked leg or arm arteries with symptoms.
- Who is left out: people with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease. So is anyone whose Part D plan already pays for a GLP-1.
- Plans that qualify: Blue Part D plans, Blue Medicare Advantage plans with drug coverage, Special Needs Plans and employer retiree plans.
- How it starts: your prescriber sends the prescription and confirms you follow a diet and exercise program. Approval lasts through December 31, 2027.
Part D can still cover Zepbound for sleep apnea or Wegovy for heart risk. In 2026, your out-of-pocket costs for covered drugs stop at $2,100 for the year.
Turning 65 on a Blue work plan
Once you enroll in Medicare, the savings cards stop, even if you keep a work plan. Plan the switch a few months ahead.
If you qualify for the Bridge on Zepbound, ask for a KwikPen prescription timed with your Medicare start. If you have sleep apnea, compare Part D plans on their Zepbound coverage, not just their premium.
Blue Medicaid plans
Some Blue companies run Medicaid plans, and those follow your state's rules. KFF counted 13 state Medicaid programs covering GLP-1s for obesity in January 2026.
Medicaid must cover approved uses such as sleep apnea and heart disease, usually after a prior authorization. The savings cards do not apply.
What a year costs on a Blue plan, covered vs not
Pen boxes and Lilly's self-pay fills last four weeks, so a year holds 13 fills. Wegovy pill bottles last 30 days, so a year holds about 12.
- Covered, copay plan, savings card: about $25 a fill, so about $300 to $325 a year.
- Blue Medicare plan with the Bridge: $50 a fill, so about $600 to $650 a year.
- Covered, with Mochi's prepaid membership: about $590 for the year plus about $325 in card copays, so about $910.
- Covered, with Ro's prepaid membership: about $890 for the year plus about $325 in copays, so about $1,210.
- Not covered, NovoCare pill: one bottle each at about $150 and $200, then about $300, so about $3,340.
- Not covered, NovoCare pen: two starter fills at about $200, then about $350, so about $4,240.
- Not covered, Lilly self-pay, staying at 5 mg: one fill at about $300, then about $400, so about $5,090.
- Not covered, Lilly self-pay, moving to 7.5 mg or more: about $300, then $400, then about $450 with on-time refills, so about $5,640.
- No program at all: about $14,100 a year for Zepbound and about $17,500 for Wegovy at 2026 list prices.
A high-deductible plan lands in between. The gap between the first line and the last is why an afternoon with your plan documents pays off.
GLP-1 providers that serve your state
Telehealth is licensed state by state. Pick your state to see who can actually prescribe and ship to you.
- SesameAll 50 states + DC$59–$99/mo, depending on the term you commit to · Success by Sesame (dedicated weight-loss / GLP-1 subscription) — Ongoing GLP-1 care with a provider of your choice, including dose changes and refill requestsSesame's weight loss program is listed as available in all 50 states; only its bundled lab pricing is unavailable in a handful of states (AZ, HI, ND, NJ, NY, OK, RI, SD, WY).
- Nu Image MedicalAll 50 states + DC$89/mo, billed every 6 months (about $534 per 6 months) · Compounded semaglutide (with vitamin B12), weekly injection, 6-month plan — The lowest Nu Image price, for women ready to prepay six monthsNu Image says it is available in all 50 states, but its terms say services may not be offered in every state, and sign-up starts by asking your state. No exclusion list is published.
- Oak Weight Loss ProgramAll 50 states + DCFrom $119/mo · Compounded semaglutide, weekly injection, 12-month plan — The lowest Oak price, for women ready to commit to a yearOak's homepage says its providers are licensed in all 50 states, but its terms say some services are only available in certain states, and one 2026 review counted 45 states. Enter your state at the start of the intake to confirm.
- JoinSkinnyAll 50 states + DC$149 per 28-day cycle, flat at every dose (3-, 6-, 12-month bundles discounted) · Compounded Semaglutide — weekly injection — First-time GLP-1 patients who want the lowest flat entry price and no dose-tier surprisesJoinSkinny does not publish a state list: it says it serves every eligible US state and confirms availability when you enter your state at sign-up; a July 2026 review lists all 50 states plus DC, subject to change.
- RoAll states except HI, LA, MS, VA$149/mo (1.5 mg), $199/mo (4 mg), $299/mo (9 mg and 25 mg) · Wegovy Pill (Oral Semaglutide) — Needle-free GLP-1; lowest-cost brand-name entry at Ro (the price rises with the dose)Ro is licensed in all 50 states and DC, but the Ro Body weight-loss program is not offered in Hawaii, Louisiana, Mississippi or Virginia.
- FoundAll 50 states + DC$169–$289/mo · Compounded semaglutide, cash pay — All-in: care, medicine and membership · $169 on a 12-month plan paid up front, $219 on 6 months, $249 on 3 months, $289 month to month · First month $179 on the monthly plan · Same price at every doseFound's platform serves all 50 states plus DC, but its own pages say prescriptions are at provider discretion and specific medications (notably compounded GLP-1s) are not available in every state.
- Gala GLP-1All 50 states + DC$179/mo, all doses included · Compounded GLP-1/GIP (incl. tirzepatide) — yearly plan — Patients sure they'll stay on treatment for a year and want the lowest flat rateGala says it has licensed providers in all 50 states; consultation format may vary with state telehealth rules.
- BetterMe Rx50 states$199 month-to-month; $159/mo on 3 months ($477), $139/mo on 6 months ($834), $99/mo on 12 months ($1,188 upfront) · Compounded semaglutide, weekly injection — The lowest flat rate on a long plan, if you are sure you will stay on treatmentBetterMe Rx says it serves all 50 states; some states require a video or phone visit. Washington, D.C. is not mentioned.
- EdenAll states except AR, LA, MS, NM$199/mo medication + $39 first month/$99/mo membership = $298/mo ongoing · Compounded Tirzepatide (injection) — Patients wanting tirzepatide's dual GIP/GLP-1 mechanism with a price that won't rise as they titrate upEden's own materials say all 50 states, but two independent 2026 reviews list Arkansas, Louisiana, Mississippi and New Mexico as not served for GLP-1; the official site could not be read directly.
- Pallas HealthAll 50 states + DC$199 every 4 weeks · First month $139 · $179 per 4 weeks on the 12-week plan ($537) · $139 per 4 weeks on the 48-week plan ($1,668 upfront) · Compounded semaglutide, weekly injection — Starting a GLP-1 at a low entry price, with the same price at every dosePallas says it accepts patients in all 50 states and DC. Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and DC require one live video visit before a prescription; everywhere else is fully online.
- ReadyRxAll states except AR, KS, KY, LA, MS, NM, SC$199/mo ($179 first month with code), billed as a 3-month block · Compounded Semaglutide — quarterly (paid up-front) — Patients committed to at least three months who want the lowest per-month rateReadyRx's site does not publish a state list; third-party reviews report it cannot prescribe compounded semaglutide in AR, KS, KY, LA, MS, NM or SC, and compounded tirzepatide is also unavailable in California and North Carolina.
- JoiAll 50 states + DC$249/mo ($149 first month), billed quarterly — $747 per 3-month supply · Compounded GLP-1/GIP (tirzepatide) — weekly injection — Plateaus on semaglutide or a preference for the dual-pathway moleculeJoi's site says compounded semaglutide is not available in every state and shows different pricing for New York and New Jersey residents; an Aug 2026 review lists all 50 states served.
- LevelsRxAll states except LAStarting at $249/mo · Compounded Semaglutide — weekly injection — First-time GLP-1 patients who want clinician video check-ins included and a price that stays the same at every doseLevelsRx's own site publishes no state list (clinicians are OpenLoop Health, which covers all 50 states); the company told a reviewer in January 2026 it serves 49 states with Louisiana excluded for now, and availability is confirmed during sign-up.
- TrimRxAll 50 states + DCfrom $259/mo (advertised entry rate); month-to-month $349 first month, then $399/mo · Compounded Tirzepatide ("GLP-1 + GIP") — injection — Patients who want tirzepatide's dual mechanism without the dose-by-dose price ladder most competitors chargeTrimRx's terms limit service to residents of the 50 US states but publish no per-state exclusion list; its intake quiz confirms whether your state can be served.
- Direct MedsAll states except MS, LA$297/mo · first month $147 with current promo · 3-month prepay $711 (about $237/mo) · 6-month prepay $882 (about $147/mo) · Compounded semaglutide, weekly injection — Starting a GLP-1 at the lowest Direct Meds price, especially on the 6-month prepayDirect Meds says it serves all US states except Mississippi and Louisiana, where state rules restrict prescribing weight-loss drugs by telehealth. The site does not say whether the hormone kit follows the same list.
- MEDGmAll 50 states + DC$299/mo month-to-month ($179 first month with code WELCOME120OFF); $199/mo on 3 months ($597), $189/mo on 6 months ($1,134), $169/mo on 12 months ($2,028), each billed upfront · Compounded semaglutide, weekly injection — First-time GLP-1 users who want a flat price at every dose and can commit to a longer plan to get the lowest rateMEDGm's terms say it serves all 50 states plus DC, but some services or medications may not be available in every state. Some states require a live video or phone visit before a prescription.
- LifeMDAll 50 states + DC$39 first month, then $149/mo · Membership — month-to-month — Patients who want to stay flexible without an annual commitmentLifeMD describes itself as a 50-state telehealth company with a nationwide mail-order pharmacy network; no state exclusions are published for the weight management program.
- NoomAll states except AL, LA, MS$129 to start, $249 ongoing · Noom Med — GLP-1Rx (compounded semaglutide) — Standard GLP-1 with full coaching platform — medication + behavioral supportNoom's GLP-1Rx program is not offered in Alabama, Louisiana or Mississippi, and its compounded-medication plans carry a further 'not available in all 50 states' footnote.
- HersAll 50 states + DC$149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg · Wegovy pill (oral semaglutide) — Lowest-cost entry into a brand-name GLP-1Hers is licensed in all 50 states, but its weight-loss FAQ says GLP-1 medications are not yet available in every state and no exclusion list is published; Puerto Rico is not served.
- Hims & HersAll 50 states + DC$149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg · Oral Wegovy (semaglutide pill) — Women who want semaglutide without injectionsHims & Hers is licensed in all 50 states, but its weight-loss FAQ says GLP-1 treatments are not yet available in every state and no exclusion list is published; Puerto Rico is not served.
- FridaysAll states except LA~$150 · Compounded semaglutide — annual — Women committed to a full year; cheapest monthly rate availableFridays' own site does not publish a state list; two 2026 reviews say 49 states with Louisiana excluded.
- Mochi HealthAll 50 states + DC$169–$278/mo · Compounded Tirzepatide — Patients who want the dual GIP/GLP-1 mechanism for greater weight loss (price scales with dose, $90–$199/mo medication + $79/mo membership)Mochi says you can join from anywhere in the United States and publishes office addresses in nearly every state plus DC; no compounded-medication state exclusions are listed.
- AmbleAll 50 states + DC$179 · Compounded semaglutide, month to month — Flexibility, no commitment beyond one monthCompounded semaglutide/tirzepatide only; in NM, KS, WV, LA and MS a short video or audio visit is required before treatment, and Amble adds 'restrictions apply'.
- PlushCareAll 50 states + DC$199/mo for the first 2 fills (0.25–0.5 mg, through Dec 31, 2026), then $349/mo up to 1 mg or $499/mo at 2 mg · Ozempic (off-label for weight loss, cash via NovoCare Pharmacy) — Cash-pay patients using PlushCare's NovoCare discount path rather than full retailPlushCare visits and brand-name GLP-1 prescriptions are available in all 50 states. Its compounded-semaglutide option, which applies only during an FDA-listed shortage, would be limited to 40 states plus DC (not AL, AK, AR, IN, KY, LA, MI, MN, SC, SD).
- Ivim HealthAll states except MS$200-$258/mo starting, climbing to ~$299-$349/mo at a mid-to-maintenance dose (medication ~$125-$183/mo + $74.99/mo membership) · Compounded Tirzepatide — Patients wanting tirzepatide's dual GIP/GLP-1 mechanism who are comfortable with a price that rises as their dose doesIvim serves 49 states plus Washington DC; Mississippi is the only state not served (help-center article last updated about a year ago).
- ZealthyAll 50 states + DCFrom $216/mo, on top of membership · Compounded Tirzepatide — Patients wanting tirzepatide's dual GIP/GLP-1 mechanism at a lower entry price than most brand-name pathsZealthy announced 50-state coverage in July 2025; its website itself does not publish a state list.
- Henry MedsAll states except AL, AK, AR, HI, LA, MS, MO, SC, TN, WV$297/mo · Compounded Semaglutide Injection — Standard weekly injectable semaglutide. About $247/mo on a 6-month prepay, about $197/mo on a 12-month prepay.Henry does not publish a state list; an Aug 2026 check of its intake found 40 states plus DC, with the ten states above missing (earlier 2026 reviews omitted Tennessee), and California orders ship slower due to compound testing rules.
- Willow36 states$299/mo · Compounded semaglutide, shot or tablet — Lowest price, the same at every dose up to 3.5 mgWillow now lists 36 states (Tennessee and Wyoming added since the earlier 33-state list); not yet in the other 14 states or DC.
- MedviAll states except ND$399/mo · First month $279 · $299/mo prepaid 12 months (shot) · Compounded tirzepatide (shot or tablet) — Tirzepatide, the stronger molecule, at a lower price than brand-name Zepbound at higher dosesMedvi's terms say to ask customer service for the current state list. 2026 reviews agree it serves every state but North Dakota. In KS, IN, MS, NM, OK and WV a short video visit may be required, and in AL and CA only the shots ship.
- Brello Health41 states$499 billed per 3-month cycle (~$166/mo), renews every 11 weeks · Compounded Tirzepatide (with B6) — 3-Month Plan — Patients wanting tirzepatide's dual GIP/GLP-1 mechanism without the price climbing as they titrate upBrello's checkout currently accepts 40 states plus DC; AL, AR, CA, CT, IN, MA, MI, NJ, NC and SC cannot be selected, its 'States We Operate In' map marks availability live, and 2026 reviews citing 48 states are out of date.
Frequently asked questions
Does Blue Cross Blue Shield cover Zepbound?+–
Sometimes. Each Blue company and each employer sets its own rules. Plans that include weight-loss drugs usually cover Zepbound after prior authorization, and several Blue companies now exclude it unless your employer adds that coverage.
Does Anthem cover Zepbound?+–
It depends on your employer's plan and the drug list it uses. Anthem is Elevance Health's Blue brand in 14 states, and its drug lists run through CarelonRx. Search Zepbound by name in your Anthem member account and look for a PA code.
Does Blue Cross cover Wegovy for weight loss?+–
Only on plans that include weight-loss drugs. Some Blue companies that exclude weight loss still cover Wegovy to lower heart risk, such as Blue Cross VT and Independence Blue Cross. BCBS of Massachusetts excludes that use too.
Does BCBS cover GLP-1s for weight loss in 2026?+–
Fewer Blue plans do than a few years ago. BCBS of Michigan, BCBS of Massachusetts, Blue Cross VT, Florida Blue and Independence Blue Cross have published exclusions for some or all of their plans. Self-funded employers can often still choose to cover these drugs.
How do I find out if my BCBS plan covers Zepbound?+–
Log in to your Blue company's member site or app and search the drug list for Zepbound. Look for PA, QL or ST codes and the tier. Then ask HR whether your plan is self-funded and whether it excludes weight-loss drugs.
Does BCBS cover Zepbound for sleep apnea?+–
Some Blue plans review it as a separate request when you have moderate to severe sleep apnea with obesity. Others do not: BCBS of South Carolina does not review it on plans without weight-loss coverage. Ask your plan how it handles this use.
Can I use the Zepbound or Wegovy savings card with a Blue Cross plan?+–
Yes, on a commercial Blue plan that covers the drug. The Zepbound card covers the single-dose pen and the Wegovy card covers the pen or pill, both from as little as $25 with a $100 monthly cap. Neither works with Medicare or Medicaid.
Does FEP Blue, the Federal Employee Program, cover Wegovy or Zepbound?+–
FEP Blue covers weight-loss drugs to treat obesity for members who meet its criteria and get prior approval. Standard, Basic and Focus each have their own drug list. For 2027, federal plans must pair this coverage with an intensive lifestyle program.
Does my Blue Cross Medicare plan cover Zepbound or Wegovy?+–
For weight loss, eligible members go through the Medicare GLP-1 Bridge at $50 a month. It covers Wegovy, Foundayo and the Zepbound KwikPen through 2027. Part D can also cover Zepbound for sleep apnea or Wegovy for heart risk.
What can I do if Blue Cross denies Zepbound?+–
Read the reason first. A paperwork denial can be appealed within 180 days, but a plan exclusion usually cannot. If the answer stays no, Lilly's self-pay KwikPen costs about $300 to $450 a month by dose.
Does menopause weight gain qualify for BCBS GLP-1 coverage?+–
Not by itself. Blue plans look at your BMI and diagnosed conditions such as high blood pressure, prediabetes, high cholesterol or sleep apnea. These often appear in midlife, so make sure each one is written in your chart.